Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Embryonic stem cell patents and human dignity.

Literature DB >> 17922198

Embryonic stem cell patents and human dignity.

Abstract

This article examines the assertion that human embryonic stem cells patents are immoral because they violate human dignity. After analyzing the concept of human dignity and its role in bioethics debates, this article argues that patents on human embryos or totipotent embryonic stem cells violate human dignity, but that patents on pluripotent or multipotent stem cells do not. Since patents on pluripotent or multipotent stem cells may still threaten human dignity by encouraging people to treat embryos as property, patent agencies should carefully monitor and control these patents to ensure that patents are not inadvertently awarded on embryos or totipotent stem cells.

Entities: Species

Mesh：

Year: 2007 PMID： 17922198 PMCID： PMC2695597 DOI： 10.1007/s10728-007-0045-9

Source DB: PubMed Journal: Health Care Anal ISSN： 1065-3058

25 in total

Embryonic stem cell patents and human dignity.

1. Respecting what we destroy. Reflections on human embryo research.

2. Embryo and stem cell research in the United States: history and politics.

3. Universal declaration on the human genome and human rights (revised draft).

4. On the moral and legal status of abortion.

5. Who or what is the preembryo?

6. Genes, religion and society: the developing views of the churches.

7. Cloning humans from the perspective of the Christian churches.

8. Dignity is a useless concept.

9. The commercialization of human stem cells: ethical and policy issues.

10. The patentability of human embryonic stem cells in Europe.

1. Defining "research" in the US and EU: contrast of Sherley v. Sebelius and Brüstle v. Greenpeace rulings.

2. Will CRISPR Germline Engineering Close the Door to an Open Future?

3. Research integrity in China: problems and prospects.

4. Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem Cells.